Team develops safe, effective RNA interference technique

A team of researchers from MIT and Alnylam Pharmaceuticals has developed safe and effective methods to perform RNA interference, a therapy that holds great promise for treating a variety of diseases including cancer and hepatitis.

"RNA interference is a tool that has a lot of people excited, and one reason for the excitement is that we hope it will provide a new method to control almost any gene in your body," said Daniel Anderson of the David H. Koch Institute for Integrative Cancer Research at MIT and the senior author of a paper on the work appearing as the cover story in Nature Biotechnology today.

Scientists see RNA interference (RNAi) as a way to turn off specific disease-causing genes. Despite this potential, researchers studying the technique have been stymied by one major problem: How to deliver RNAi agents to target tissues.

Now, the MIT/Alnylam team has developed a library of new molecules that successfully delivered RNA interference agents in several animals, including mice, rats and cynomolgus monkeys. The team hopes to test the delivery materials in human clinical trials within the next few years.

RNAi works by disrupting the flow of genetic information from a cell's nucleus to the protein-building machinery of the cell. Gene expression can be turned on or off by interfering with messenger RNA, which carries that information.

One way to deliver RNAi is to package siRNA (short interfering RNA) inside nanoparticles that can deliver it directly to the target cell.

In previous studies, lipids (fat-soluble molecules such as fats, waxes and cholesterol) have shown promise as RNAi delivery agents. However, only a limited number of different materials had been developed when those studies were conducted.

Using a new synthesis scheme that allows for high-speed production, the researchers created a huge library of lipid-like molecules called lipidoids. A major advantage of these chemical methods is that they facilitate production of a large variety of different molecules, which could be customized for different RNAi therapies and drug-delivery problems.

The MIT team found several lipidoids that successfully delivered siRNA to the liver, which may provide a therapy for diseases ranging from cancer to viral infection, Anderson said. They also demonstrated siRNA delivery to the lungs, where it blocked genes expressed by respiratory syncytial virus that had infected the lungs. The lipidoids were also able to deliver siRNA to immune cells called macrophages.

In some cases, the effects of a single RNAi injection lasted up to four weeks. The researchers also showed that they could block two genes at once, raising the possibility of treating diseases that involve multiple genes.

The delivery system also proved effective with another type of RNA interference, which involves disrupting microRNA (very short strands of RNA that help control gene expression).

"For the first time, we've got a lot of formulations to choose from," Anderson said. "In the next five years, we expect to push this technology forward in a number of different clinical and drug-delivery applications."

The first author of the paper is Akin Akinc, who received a PhD in chemical engineering from MIT in 2003 and is now at Alnylam. Andreas Zumbuehl, now at the University of Geneva; MIT students Michael Goldberg, Elizaveta Leshchiner, Valentina Busini, Sergio Bacallado, David Nguyen and Jason Fuller; and Institute Professor Robert Langer are also authors of the paper.

Source: MIT

Related stories:

New insights into cellular reprogramming revealed by genomic analysis
The ability to drive somatic, or fully differentiated, human cells back to a pluripotent or “stem cell” state would overcome many of the significant scientific and social challenges to the use of embryo-derived stem cells and help realize the promise of regenerative medicine.
MIT develops lecture search engine to aid students
Imagine you are taking an introductory biology course. You're studying for an exam and realize it would be helpful to revisit the professor's explanation of RNA interference. Fortunately for you, a digital recording of the lecture is online, but the 10-minute explanation you want is buried in a 90-minute lecture you don't have time to watch.
Worm study sheds light on human aging, inherited diseases
Microscopic worms used for scientific research are living longer despite cellular defects, a discovery that is shedding light on how the human body ages and how doctors could one day limit or reverse genetic mutations that cause inherited diseases, according to a new University of Colorado at Boulder study.
Team demos safety of RNA therapy
Researchers from MIT, Alnylam Pharmaceuticals and other institutions have demonstrated the safety of a promising type of genetic therapy that could lead to treatments for a wide range of diseases such as cancer.
MIT invents 'lab on a chip' to automate gene studies
Genetic studies on whole animals can now be done dramatically faster using a new microfluidic chip developed by engineers at MIT.
Screening approach leads to discovery of gene linked to breast cancer
Using a novel three-part screening process, scientists at Dana-Farber Cancer Institute have identified a gene that is made inappropriately in about a third of all breast cancers. The discovery, reached in collaboration with researchers at Brigham and Women's Hospital (BWH) and the Broad Institute of Harvard and MIT, is reported in the June 15, 2007 issue of the journal Cell.
Nobel Prize for Medicine: Silence is golden for US laureates (Update 3)
Two US scientists, Andrew Fire and Craig Mello, on Monday won the Nobel Medicine Prize for discovering how to silence malfunctioning genes, a breakthrough which could lead to an era of new therapies to reverse crippling disease.
The 21st century tomato
When tomatoes ripen in our gardens, we watch them turn gradually from hard, green globules to brightly colored, aromatic, and tasty fruits. This familiar and seemingly commonplace transformation masks a seething mass of components interacting in a well-regulated albeit highly complex manner. For generations, agriculturalists and scientists have bred tomatoes for size, shape, texture, flavor, shelf-life, and nutrient composition, more or less, one trait at a time. With the advent of molecular biology, mutagenesis and genetic transformation could produce tomatoes that were more easily harvested or transported or turned into tomato paste. Frequently, however, optimizing for one trait led to deterioration in another. For example, improving flavor could have a negative effect on yield.

News discussion:

General Science news